Table 2 Correlations between RBM24 mRNA expression and clinicopathological characteristics.
From: RBM24 exacerbates bladder cancer progression by forming a Runx1t1/TCF4/miR-625-5p feedback loop
Characteristic | Number of patients (%) | RBM24 expression | P-valuea | |
|---|---|---|---|---|
Low (%) | High (%) | |||
Total no. of patients | 161 | 89 | 72 | Â |
Age (years) | ||||
≤63b | 70 | 37 (52.86) | 33 (47.14) | 0.772 |
>63 | 91 | 46 (50.55) | 45 (49.45) | |
Gender | ||||
Male | 102 | 56 (54.90) | 46 (45.10) | 0.264 |
Female | 59 | 27 (45.76) | 32 (54.24) | |
Tumor size (cm) | ||||
≤3.0c | 106 | 58 (54.72) | 48 (45.28) | 0.001 |
>3.0 | 55 | 15 (27.27) | 40 (72.73) | |
Tumor grade | ||||
Low | 97 | 45 (46.39) | 52 (53.61) | 0.221 |
High | 64 | 36 (56.25) | 28 (43.75) | |
T classification | ||||
Ta, T1 | 105 | 46 (43.81) | 59 (56.19) | 0.041 |
T2-T4 | 56 | 34 (60.71) | 22 (39.29) | |
pN status | ||||
pN− | 114 | 55 (48.25) | 59 (51.75) | 0.120 |
pN+ | 47 | 29 (61.70) | 18 (38.30) | |
Tumor multiplicity | ||||
Unifocal | 69 | 28 (40.58) | 41 (59.42) | 0.818 |
Multifocal | 92 | 39 (42.39) | 53 (57.61) | |
